Robert Olstein’s Hologic HOLX Stock Holding History

Robert Olstein’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-113,000	Closed	-$7.63M	–	104
2025 Q3	$7.63M	Sell	113,000 -2,000	-2%	-$133K	1.44%	20
2025 Q2	$7.49M	Hold	115,000	–	–	1.4%	22
2025 Q1	$7.1M	Buy	115,000 +25,000	+28%	+$1.66M	1.31%	33
2024 Q4	$6.49M	Buy	90,000 +5,000	+6%	+$391K	1.14%	43
2024 Q3	$6.92M	Sell	85,000 -7,000	-8%	-$560K	1.18%	47
2024 Q2	$6.83M	Hold	92,000	–	–	1.22%	42
2024 Q1	$7.17M	Hold	92,000	–	–	1.17%	46
2023 Q4	$6.57M	Buy	92,000 +2,000	+2%	+$139K	1.11%	49
2023 Q3	$6.25M	Buy	90,000 +37,000	+70%	+$2.8M	1.07%	52
2023 Q2	$4.29M	Sell	53,000 -3,000	-5%	-$245K	0.69%	71
2023 Q1	$4.52M	Sell	56,000 -19,000	-25%	-$1.53M	0.71%	70
2022 Q4	$5.61M	Sell	75,000 -17,000	-18%	-$1.21M	0.88%	67
2022 Q3	$5.94M	Hold	92,000	–	–	0.99%	61
2022 Q2	$6.38M	Sell	92,000 -17,000	-16%	-$1.26M	0.96%	59
2022 Q1	$8.37M	Buy	109,000 +24,000	+28%	+$1.73M	1.05%	47
2021 Q4	$6.51M	Buy	85,000 +9,190	+12%	+$676K	0.78%	67
2021 Q3	$5.6M	Sell	75,810 -19,190	-20%	-$1.44M	0.69%	68
2021 Q2	$6.34M	Buy	+95,000	New	+$6.35M	0.8%	60
2020 Q3	–	Sell	-25,000	Closed	-$1.43M	–	105
2020 Q2	$1.43M	Sell	25,000 -65,000	-72%	-$3.19M	0.27%	92
2020 Q1	$3.16M	Buy	+90,000	New	+$4.29M	0.69%	73
2019 Q3	–	Sell	-55,500	Closed	-$2.67M	–	113
2019 Q2	$2.67M	Sell	55,500 -5,500	-9%	-$254K	0.43%	95
2019 Q1	$2.95M	Sell	61,000 -7,000	-10%	-$316K	0.49%	91
2018 Q4	$2.79M	Sell	68,000 -53,900	-44%	-$2.21M	0.46%	93
2018 Q3	$5M	Sell	121,900 -6,100	-5%	-$247K	0.67%	76
2018 Q2	$5.09M	Sell	128,000 -39,700	-24%	-$1.53M	0.67%	73
2018 Q1	$6.26M	Buy	167,700 +20,000	+14%	+$808K	0.8%	59
2017 Q4	$6.31M	Buy	147,700 +28,000	+23%	+$1.12M	0.8%	54
2017 Q3	$4.39M	Buy	119,700 +28,200	+31%	+$1.14M	0.57%	80
2017 Q2	$4.15M	Sell	91,500 -75,500	-45%	-$3.33M	0.53%	85
2017 Q1	$7.11M	Sell	167,000 -17,000	-9%	-$693K	0.91%	50
2016 Q4	$7.38M	Sell	184,000 -3,000	-2%	-$116K	0.95%	49
2016 Q3	$7.26M	Hold	187,000	–	–	0.96%	47
2016 Q2	$6.47M	Buy	+187,000	New	+$6.48M	0.87%	55

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Robert Olstein's HOLX Position: Q4 2025 in Review

Robert Olstein sold out of Hologic (HOLX) in Q4 2025, closing a stake of 113,000 shares — an estimated $7.63M sold.

Robert Olstein first reported a position in HOLX in Q2 2016 and held it in 33 quarters. The position peaked at $8.37M in Q1 2022. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

Robert Olstein reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
Robert Olstein sold 113,000 Hologic shares in Q4 2025, an estimated $7.63M.
Robert Olstein first reported a position in Hologic in Q2 2016 and held it in 33 quarters.
Robert Olstein's Hologic position peaked at $8.37M in Q1 2022.
749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Olstein Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.